Seqirus opens world-class cell-based vaccine and antivenom manufacturing facility

Australia has taken a significant step toward securing its vaccine sovereignty, with Health Minister Mark Butler opening CSL Seqirus’ new $1 billion, state-of-the-art cell-based influenza vaccine and antivenom manufacturing facility in Melbourne. …